A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine

The Brighton Collaboration Benefit-Risk Assessment of VAccines by TechnolOgy (BRAVATO) Working Group has prepared standardized templates to describe the key considerations for the benefit-risk assessment of several vaccine platform technologies, including protein subunit vaccines. This article uses...

Descripción completa

Detalles Bibliográficos
Autores principales: Estephan, Lila, Liu, Luke Tzu-Chi, Lien, Chia En, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981522/
https://www.ncbi.nlm.nih.gov/pubmed/36925422
http://dx.doi.org/10.1016/j.vaccine.2023.02.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981522/
https://www.ncbi.nlm.nih.gov/pubmed/36925422
http://dx.doi.org/10.1016/j.vaccine.2023.02.083

Ejemplares similares